ReviewWorld journal of microbiology & biotechnology2025
Modification and applications of glucose oxidase: optimization strategies and high-throughput screening technologies.
Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineering a broad-spectrum glucose oxidase via substrate channel and linker design for enhanced lignocellulose bioconversion.Synthetic and systems biotechnology · 2026Article
- Biomineralization of Glucose Oxidase fromBioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Glucose oxidase (GOD), an oxidoreductase (EC 1.1.3.4), catalyzes the oxidation of β-D-glucose to gluconic acid using molecular oxygen as the electron acceptor, with concomitant generation of hydrogen peroxide. Owing to its versatile catalytic properties, GOD has garnered significant attention across diverse fields, including food and beverage manufacture, agriculture, biosensors and biotechnology. However, the inherent limitations of native enzymes, including susceptibility to inactivation under harsh conditions and insufficient catalytic efficiency, restrict their practical utility in advanced industry. This review systematically summarizes recent advances in molecular engineering strategies for GOD optimization, focusing on rational design and directed evolution approaches to improve its functional robustness and application adaptability in the bioeconomy. Furthermore, we highlight the prospective role of artificial intelligence (AI) and machine learning (ML) in addressing the classical activity-stability trade-off, enabling data-driven prediction of mutation hotspots and dynamic regulation of enzymatic properties. By integrating computational biology with experimental validation, this work proposes a theoretical framework and technical roadmap for developing "tailored" GOD variants that meet precise industrial requirements. The insights presented herein aim to bridge the gap between fundamental enzyme research and scalable biomanufacturing, fostering innovation in sustainable biotechnology.
Indexed as
Identifiers
40650823What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.